Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

finscreener stocktwits page

CorMedix, Inc.

AMEX: CRMDHealthcare / Biotechnology / USA
1.69-0.0900-5.06%Vol 8 308 0761Y Perf 203.57%
Feb 15th, 2019 16:00
BID1.70 ASK1.71
Open1.74 Previous Close1.78
Pre-Market1.75 After-Trading1.69
 -0.03 -1.69%  - -%
Target Price
4.75 
Analyst Rating
Strong Buy 1.00
Potencial %
181.07 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
100/100/100 
Value Ranking
 —    -
Insiders Value % 3/6/12M
100/100/100 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
100/100/100 
Income Ranking
 —    -
Market Cap (mil)178 
Earnings Rating
Strong Sell
Price Range Ratio 52wk %
59.14 
Earnings Date
18th Mar 2019

Today's Price Range

1.501.77

 

52wk Range

0.17002.74

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Month
-12.44%
3 Months
72.45%
6 Months
259.57%
1 Year
203.57%
3 Years
-13.78%
5 Years
-23.18%

Quotes

Name / TickerPriceChg.Chg.%
CRMD1.69-0.0900-5.06
AAPL170.42-0.3800-0.22
GOOG1 113.65-8.0200-0.72
MSFT108.221.32001.23
XOM77.711.44001.89
WFC49.220.70001.44
JNJ136.382.07001.54
FB162.50-1.4500-0.88
GE10.090.05000.50
JPM105.553.13003.06
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
0.40
Current Ratio
0.40
Long Term Debt to Total Capital
-
Total Debt to Equity
-
Interest Coverage
-8 390.40
Leverage Ratio -1.60
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
37.20
EBIT Margin
-7 923.40
EBITDA Margin
-7 909.80
Pre-tax Profit Margin
-10 101.00
Profit Margin
-
ValuationValueIndustryS&P 500US Markets
PE Ratio
-
PB Ratio
60.71
PS Ratios
568.07
Price to Cash Flow
-
Price to Free Cash Flow
-12.80
Cash Flow Per Share
-0.30
Price to Tangible Book
-22.31
Book Value per Share
-0.09
Enterprise Value (in ths.)
205 434
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)
-194.26
ROE last 12 Months
-44 174.40
Return on Assets (5Y Avg)
-193.98
ROA last 12 Months
-357.54
Return on Capital (5Y Avg)
-154.10
ROC last 12 Months
-44 227.50
Return on invested Capital Q
-
Return on invested Capital Y
-264.85
Assets Turnover
0.00
Receivables Turnover
1.20
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
403
Revenue per Share
0.00
Revenue Growth 3 Years
22.70
Revenue Growth 5 Years
143.34
DividendsValueIndustryS&P 500US Markets
Dividend Yield
-
Dividend Rate
-
Dividend Growth 3 Years
-
Dividend Growth 5 Years
-

Earnings HistoryEstimateReportedSurprise %
Q03 2018-0.06-0.11-83.33
Q02 2018-0.10-0.100.00
Q01 2018-0.10-0.14-40.00
Q04 2017--0.15-
Q02 2017-0.16-0.1412.50
Q01 2017-0.15-0.19-26.67
Q04 2016-0.22-0.1627.27
Q03 2016-0.16-0.23-43.75
Earnings Per EndEstimateRevision %Trend
12/2018 QR-0.08-60.00Negative
12/2018 FY-0.42-31.25Negative
3/2019 QR-0.07-75.00Negative
12/2019 FY-0.27-92.86Negative
Next Report Date18th Mar 2019
Estimated EPS Next Report-0.08
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume8 308 076
Shares Outstanding (in ths.)105 310
Trades Count9 296
Dollar Volume13 103 054
Avg. Volume3 601 954
Avg. Weekly Volume8 853 106
Avg. Monthly Volume3 854 797
Avg. Quarterly Volume3 084 689

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

59%41%

Bearish Bullish

63%37%

Bearish Bullish

53%47%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (100.00 %)
2 (100.00 %)
1 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

There are no comments yet.

News